News

Our latest press releases, media appearances and topical commentary.





News
16 December 2022
Alchemab Therapeutics and Medicines Discovery Catapult Awarded £1.7 Million Grant from Innovate UK

Company plans to triage a panel of antibodies towards first in human studies





News
06 December 2022
Medicines Discovery Catapult Welcomes Andrea Stott as Chief Operating Officer

Andrea Stott joins Medicines Discovery Catapult (MDC) as Chief Operating Officer, bringing over 25 years of international business and operational management experience to the role.


News
30 November 2022
UK SPINE: Honing In on Healthy Ageing

Accelerating medicines discovery to close the gap between healthspan and lifespan


News
18 November 2022
Chris Molloy Wins OBN Special Recognition Award

Prestigious industry awards recognise Professor Molloy’s contribution to life sciences


News
03 November 2022
Medicines Discovery Catapult and Xerion Healthcare Secure Funding for Innovative Brain Tumour Treatment

Innovate UK SMART Grant awarded to accelerate progress to clinical trials


News
26 October 2022
Medicines Discovery Catapult Appoints International Entrepreneur Volker Hirsch to Bolster Commercial Expertise

New appointment reflects ambition for growth to drive drug discovery innovation


News
21 October 2022
Medicines Discovery Catapult Inspires Cheshire’s Future Scientists

School engagement programme reaches hundreds of local school children






Partner with us and make sure your next move counts

See how we can help support you with your next drug discovery project.

Speak to us



We are ISO 45001 certified 

The world’s first international standard for occupational health and safety. The accreditation has been certified by Interface NRM, a UKAS and ASI–accredited certification body.











Medicines Discovery Catapult